Logo
ANGIOEDEMA TREATMENT MARKET ANALYSIS
  2. / Market Insights
  3. Angioedema Treatment Market Analysis
all report title image

ANGIOEDEMA TREATMENT MARKET ANALYSIS

Angioedema Treatment Market, by Condition Type (Allergic Angioedema, Drug-induced Angioedema, Idiopathic Angioedema, and Hereditary Angioedema (HAE)), by Drug Type (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, and Others), by Route Of Administration (Injection and Oral), by Distribution Channel, and by Geography- Global Industry Insights, Trends, Outlook, And Opportunity Analysis, 2022-2028

  • To Be Published : Sep 2024
  • Code : CMI1371
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Key players in angioedema treatment market include Shire plc, CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. In 2017, Shire plc. received European Commission (EC) approval for label extension, that increases indication for FIRAZYR (icatibant injection), broadening use to adolescents and children aged 2 years and older, with HAE caused by C1-esterase-inhibitor (C1-INH) deficiency.

Angioedema Treatment Market Report Snapshots

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.